Assignee
TOSK INC
US18 patents
Top patents by PatentIndex Score
US7998967B2Aug 16, 2011
Methotrexate adjuvants to reduce toxicity and methods for using the same
TOSK INC15 citations91
US6365129B1Apr 2, 2002
Invivo high throughput toxicology screening method
TOSK INC20 citations90
USRE48253EOct 13, 2020
Methotrexate adjuvants to reduce toxicity and methods for using the same
TOSK INC5 citations82
US9382287B2Jul 5, 2016
Methotrexate adjuvants to reduce toxicity and methods for using the same
TOSK INC5 citations82
US11945803B2Apr 2, 2024
Modulators of RAS GTPase
TOSK INC3 citations71
US6855504B2Feb 15, 2005
In vivo high throughput toxicology screening method
TOSK INC10 citations71
US6316690B1Nov 13, 2001
Non-mammalian transgenic animal model for cellular proliferative diseases
TOSK INC13 citations71
US11446303B2Sep 20, 2022
Uridine phosphorylase (UPase) inhibitors for treatment of liver conditions
TOSK INC3 citations67
US12508265B2Dec 30, 2025
Methods and compositions for reducing radiation induced toxicity
TOSK INC0 citations60
US12419893B2Sep 23, 2025
Methods and compositions for maximizing the prevention and/or reduction of various maladies and drug side-effects using uridine
TOSK INC0 citations60
US12194043B2Jan 14, 2025
Uridine phosphorylase inhibitors to treat or prevent pulmonary disease
TOSK INC0 citations60
US12109222B2Oct 8, 2024
Methods and compositions for treating mucositis
TOSK INC0 citations60
US12486255B2Dec 2, 2025
Modulators of RAS GTPase
TOSK INC0 citations59
US9468613B2Oct 18, 2016
Doxorubicin adjuvants to reduce toxicity and methods for using the same
TOSK INC0 citations51
US12528796B2Jan 20, 2026
Modulators of RAS GTPase
TOSK INC0 citations48
US12180220B2Dec 31, 2024
Heteroaryl modulators of RAS GTPase
TOSK INC0 citations48
US11390626B2Jul 19, 2022
Pyrazolopyrimidine modulators of RAS GTPase
TOSK INC0 citations48
US10660318B2May 26, 2020
Non-mammalian RAS transgenic animal model
TOSK INC0 citations44